CLINICAL TRIAL PRODUCT: payments to doctors
Payments that named CLINICAL TRIAL PRODUCT as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $5.3M
- Providers
- 1,292
- Transactions
- 5,593
- Average per transaction
- $946
The per-transaction average — $946 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,292 providers the average total is $4,093, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Boston Scientific | $5,287,289 | 100.0% |
| Baylis Medical Company Inc | $988 | 0.0% |